dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Terviseamet
Väljaminev dokumentAvalik

Kiri

Terviseamet · 13. november 2024
Viit
11.1-2/24/11717-2
Registreeritud
13. november 2024
Dokumendi liik
Väljaminev dokument
Adressaat
Advena
Saabumis/saatmisviis
vastutaja nimeliselt e-posti aadressilt välja saadetud
Funktsioon
11.1 SULETUD 2025 Turustamise järgne järelevalve (post-marketing surveillance)
Sari
11.1-2 Kirjavahetus Eesti turule lastavatest/kasutusele võetavatest/levitatavatest seadmetest MSA kaudu teavitamiseks
Toimik
11.1-2/2023
Vastutaja
Karl Kalev Türk (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond)

Failid

  • 📎Vs_ Medical Device Notification Prior to Placing Medical Device on the Market.msg130 KB

Sisu (failidest)

Saatja: Meditsiiniseadmed (Medical Devices) </O=SOTSIAALMINISTEERIUM/OU=FIRST ADMINISTRATIVE GROUP/CN=RECIPIENTS/CN=MSOC5ACD8534204CFDEC17D568B7204AE5C891A7D> Saaja: [email protected] Teema: Vs: Medical Device Notification Prior to Placing Medical Device on the Market Dear Sam, Thank you for your enquiry. In Estonia, medical devices and medicines are located in different institutions. Therefore, we, the Estonian Health Board, who are the competent authority for medical devices, are responsible for addressing them. Here are the answers to your questions: * Does the manufacturer need to submit a notification prior to placing their device on the Estonian Market? There is a distribution notification requirement in Estonia which is based on Estonian Medical Devices Act § 26 (4) (https://www.riigiteataja.ee/en/eli/ee/524012023001/consolide/current) which says: Every undertaking who distributes on the market of Estonia a system or procedure pack of medical devices according to Article 22 of Regulation (EU) 2017/745 of the European Parliament and of the Council or a class IIa, IIb or III medical device classified according to Regulation (EU) 2017/745 of the European Parliament and of the Council or Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical or Council Directive 93/42/EEC concerning medical devices or class B, C or D in vitro diagnostic medical devices classified according to Annex VIII of Regulation (EU) 2017/746 of the European Parliament and of the Council, shall notify the Health Board thereof within 10 days after distribution of the relevant medical device for the first time. The distribution notification can be done through Estonian Medical Device Database (EMDDB, https://msa.sm.ee/). Therefore, the notifications are mainly for distributors, but in the case of direct distribution from the manufacturer, the manufacturer shall also notify us about the distribution. If we are talking about Estonian manufacturers or ARs located in Estonia, then they have an obligation to notify us of placing the class I medical device or IVD medical device on the market 10 days in advance until EUDAMED is mandatory. This also can be done through the same aforementioned national database. * Do they still need to submit the notification if they are registered on EUDAMED? The distribution notification is separate from the EUDAMED registrations. As you may know, there are no distributors in EUDAMED listed, meaning there is no information what devices are made available in Estonia and by who. This information is necessary for us to conduct effective market surveillance. * Can the Authorized Representative submit the notification on behalf of the manufacturer? If there is a PoA to represent the company, then yes. Please do not hesitate to contact me for further information or any questions. Best regards, Karl Kalev Türk Chief Specialist Department of Medical Devices Phone +372 5648 5663 [email protected]<mailto:[email protected]> | [email protected]<mailto:[email protected]> [cid:[email protected]] Republic of Estonia Terviseamet | Health Board +372 794 3500 [email protected]<mailto:[email protected]> www.terviseamet.ee<http://www.terviseamet.ee/> Paldiski mnt 81, 10614 Tallinn Estonia This e-mail is confidential and meant for use by the person named in the letterhead. Any use in any way or copying of it by a person not marked as the addressee thereof is prohibited. If you have got this e-mail by mistake, please notify of it the sender without delay and delete the received e-mail together with all its attachments. From: Sam Attard <[email protected]<mailto:[email protected]>> Sent: esmaspäev, 24. aprill 2023 10:44 To: Ravimiamet <[email protected]<mailto:[email protected]>> Subject: Medical Device Notification Prior to Placing Medical Device on the Market Dear State Agency of Medicines, We trust this email finds you well. We are an authorised representative based in Malta and we represent a number of medical device manufacturers all over the world. We are aware that in some EU countries, such as Italy, the manufacturer will have to submit a notification or register their device on a national database prior to placing the medical device on the national market. Our questions are the following; * Does the manufacturer need to submit a notification prior to placing their device on the Estonian Market? * Do they still need to submit the notification if they are registered on EUDAMED? * Can the Authorized Representative submit the notification on behalf of the manufacturer? We look forward to hearing from you and taking you in advance for your time. Wishing you a fantastic week ahead. Kindest Regards, Sam Attard Regulatory Associate [cid:[email protected]]<http://www.advena.mt/> Advena. t: +356 2546 6689 e: [email protected]<mailto:[email protected]> a: Tower Business Centre, 2nd Flr, Tower Street, Swatar, BKR 4013, Malta w: www.advena.mt<http://www.advena.mt/> Follow us on: [Logo, icon Description automatically generated] <https://www.linkedin.com/company/advena-ltd./?viewAsMember=true> [Logo Description automatically generated] <https://twitter.com/AdvenaMalta> For Regulatory Updates Subscribe to our Newsletter: [A blue sign with white text Description automatically generated with low confidence] <https://advena.us10.list-manage.com/subscribe?u=67ce44d672cae6397890ccd5b&id=fda73b3c42> IMPORTANT: This e-mail and any resulting email thread, including attachments, may contain confidential information. If you are not the intended recipient it may be unlawful for you to read, copy, distribute, disclose, or otherwise use the information contained in this e-mail. If you have received this email in error, please notify the sender by email and destroy/delete all copies immediately. Errors and omissions may occur in the contents of this e-mail arising out of or in connection with data transmission, network malfunction or failure, machine or software error or malfunction, or operator/operation error. Advena accepts no responsibility for any such errors or omissions, and you are advised to confirm the accuracy of the contents of this e-mail before relying on it for any purpose. Registered offices: Advena Ltd - Tower Business Centre, 2nd Flr, Tower Street, Swatar, BKR 4013, Malta. Company registered in Malta: C 76865. Advena Services Ltd - Tower Business Centre, 2nd Flr, Tower Street, Swatar, BKR 4013, Malta. Company registered in Malta: C 103067. Parent Company: Advena Malta (Holdings) Ltd - Highdown House, 11 Highdown Road, Leamington Spa, England, CV31 1XT United Kingdom. Reg No 13789474
Allikas: Terviseamet dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel